OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

ADDEX N/  CH0029850754  /

SIX Swiss Exchange
26/04/2024  17:31:30 Chg. +0.0005 Volume Bid18:31:54 Ask18:31:54 Market Capitalization Dividend Y. P/E Ratio
0.1155CHF +0.43% 1.83 mill.
Turnover: 196,613.1775		 0.1050Bid Size: 10,000 0.1210Ask Size: 13,999 20.59 mill.CHF - -
GlobeNewswire 19/04 Addex to Present at the Swiss Biotech Day 2024
GlobeNewswire 18/04 Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 11/04 Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire 03/04 Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire 14/03 Addex to Present at the Bio-Europe Spring 2024 Conference
GlobeNewswire 31/01 Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire 09/01 Addex to Present at the Swiss Equities Baader Conference
GlobeNewswire 05/01 Addex to Present at Biotech Showcase™ 2024
GlobeNewswire 14/12/2023 Addex Creates Treasury Shares
GlobeNewswire 29/11/2023 Addex Reports Q3 2023 Financial Results and Provides Corporate Update
GlobeNewswire 28/11/2023 Addex Convenes Extraordinary General Meeting
GlobeNewswire 23/11/2023 Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
GlobeNewswire 14/11/2023 Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients
GlobeNewswire 08/11/2023 Addex Regains Nasdaq Listing Compliance
GlobeNewswire 07/11/2023 US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson's Disease, According to Spher...
GlobeNewswire 02/11/2023 Addex Announces Participation in the Bio-Europe 2023 Conference
GlobeNewswire 20/10/2023 Addex Completes ADS Ratio Change
GlobeNewswire 06/10/2023 Addex Announces Plan to Implement ADS Ratio Change
GlobeNewswire 20/09/2023 Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
GlobeNewswire 06/09/2023 Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 05/09/2023 Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024
GlobeNewswire 04/09/2023 Addex’s Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain
GlobeNewswire 24/03/2022 Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences
GlobeNewswire 10/03/2022 Addex Reports Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire 07/03/2022 Addex Therapeutics to Release Full-Year 2021 Financial Results and Host Conference Call on March 10,...